Health Care & Life Sciences » Biotechnology | Chabiotech Co. Ltd.

Chabiotech Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
386,835
345,345
393,782
449,261
418,882
Cost of Goods Sold (COGS) incl. D&A
302,990
294,906
269,562
300,272
297,098
Gross Income
83,844
50,439
124,219
148,989
121,784
SG&A Expense
55,031
37,340
101,017
103,216
119,107
EBIT
-
11,663
-
39,363
3,073
Unusual Expense
8,647
6,797
26,017
67
49,719
Non Operating Income/Expense
1,373
372
1,751
1,466
508
Interest Expense
3,434
2,307
2,336
3,686
8,892
Pretax Income
21,141
7,288
5,328
41,448
57,258
Income Tax
9,050
4,726
7,389
13,768
256
Equity in Affiliates
376
98
185
314
-
Consolidated Net Income
11,714
2,464
12,903
27,366
57,513
Net Income
11,308
4,721
14,957
16,871
57,290
Net Income After Extraordinaries
2,833
5,109
14,956
16,862
57,290
Net Income Available to Common
25,449
9,694
14,957
16,880
57,290
EPS (Basic)
534.26
79.00
305.18
343.38
1,163.00
Basic Shares Outstanding
48
55
49
49
49
EPS (Diluted)
534.55
78.64
305.17
310.19
1,162.63
Diluted Shares Outstanding
48
55
49
51
49
EBITDA
49,551
24,652
33,587
54,565
9,961
Other Operating Expense
865
1,436
5,487
6,410
5,750
Non-Operating Interest Income
3,900
5,101
3,558
4,238
3,916
Minority Interest Expense
406
7,185
2,054
10,495
223
Equity in Affiliates (Pretax)
-
-
-
-
2

About Chabiotech Co.

View Profile
Address
3rd Floor, Pie'n Polus Building
Seoul SL 06062
Korea, Republic Of
Employees -
Website http://www.chabio.co.kr
Updated 09/14/2018
Cha Biotech Co., Ltd. engages in the research of cell therapy and storage of cord blood. It operates through the following business: Cell Therapy Development, Bio, Chaum, and Bio Insurance. The Cell Therapy Development business develops and commercializes cell therapy.